cannabidiol, CBD, Food and Drug Administration, FDA, regulation, cannabis
It is difficult today to read the news, browse social media, or even shop in some stores without encountering people extolling the virtues of cannabidiol (“CBD”) or questioning its therapeutic value. The Food and Drug Administration (“FDA”) has been challenged by the proliferation of CBD in many markets. The hype has not escaped the FDA’s notice, but a federal agency is not poised to quickly respond to trends like these, therefore, the agency has yet to promulgate a full set of regulations.
Catt, H. (2020). Going Hemp Wild: Understanding the Challenges and Opportunities for FDA Regulation of CBD in Food Products. Journal of Food Law & Policy, 15(2). Retrieved from https://scholarworks.uark.edu/jflp/vol15/iss2/8